Oramed Pharmaceuticals Inc. Share Price Deutsche Boerse AG
Equities
OJU1
US68403P2039
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.267 EUR | +12.01% | +12.56% | +8.42% |
26/06 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
26/06 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
Sales 2024 * | 8L 7L 6.26Cr | Sales 2025 * | 20L 18.7L 17Cr | Capitalization | 10Cr 9.76Cr 870.84Cr |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | -1.4Cr -1.31Cr -116.76Cr | EV / Sales 2024 * | 139 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 52.2 x |
P/E ratio 2024 * |
-268
x | P/E ratio 2025 * |
-8.12
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.51% |
1 day | +12.01% | ||
1 week | +12.56% | ||
Current month | +13.07% | ||
1 month | +6.43% | ||
3 months | -9.43% | ||
6 months | +16.23% | ||
Current year | +8.42% |
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14/13/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/07/23 |
Date | Price | Change | Volume |
---|---|---|---|
27/24/27 | 2.267 | +12.01% | 0 |
26/24/26 | 2.024 | +0.35% | 0 |
25/24/25 | 2.017 | +0.50% | 0 |
24/24/24 | 2.007 | +0.30% | 0 |
21/24/21 | 2.001 | -0.65% | 0 |
Delayed Quote Deutsche Boerse AG, June 27, 2024 at 11:33 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.85% | 4.69TCr | |
+37.63% | 3.91TCr | |
-8.05% | 3.85TCr | |
+29.04% | 3.1TCr | |
-13.75% | 2.61TCr | |
+10.65% | 2.59TCr | |
+38.43% | 1.25TCr | |
-6.92% | 1.14TCr | |
-12.29% | 1.06TCr |
- Stock Market
- Equities
- ORMP Stock
- OJU1 Stock